Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics to Release First Quarter 2015 Financial Results, Host Annual Stockholder Meeting

SAN DIEGO, May 7, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that it...
April 13, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Initiates Pivotal Phase 3 Clinical Trials for LIPO-202, the First Non-Invasive Injectable Drug Candidate for Reduction of Subcutaneous Abdominal Fat

SAN DIEGO, April 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
April 08, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics to Present at Needham & Company's 14th Annual Healthcare Conference

SAN DIEGO, April 8, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
March 26, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results

SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
March 23, 2015 09:30 ET | Source: Neothetics, Inc.

Neothetics Initiates Study to Evaluate Safety of Retreatment With LIPO-202 for Body Contouring

SAN DIEGO, March 23, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced it has...
March 04, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics to Present at the 27th Annual Roth Conference

SAN DIEGO, March 4, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
February 25, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics to Present at Cowen and Company 35th Annual Health Care Conference

SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
February 12, 2015 08:00 ET | Source: Neothetics, Inc.

Leading Aesthetic Physicians Join Neothetics' Newly Formed Corporate Advisory Board

SAN DIEGO, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
December 01, 2014 08:00 ET | Source: Neothetics, Inc.

Neothetics Announces Closing of Upsized Initial Public Offering

SAN DIEGO, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
November 19, 2014 19:35 ET | Source: Neothetics, Inc.

Neothetics Prices Initial Public Offering

SAN DIEGO, Nov. 19, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...

keyboard_arrow_left Previous Page